Antagonist drug Normal BUN Quality improvement Therapeutic classification Free! Bioavailability Agonist drug Adverse effect Pharmacokinetics Pharmacologic classification Sensoristasis National Patient Safety Goal The Joint Commission Potency Normal GFR Half- life Onset of action Therapeutic effect Additive effects Side effect Peak and Trough levels Peak action Never Event Pharmacodynamics Normal ALT Antagonistic effects Caring Quality assurance Incompatible Systematic review Efficacy RACE Loading dose First- Pass effect Informatics Sensory Perception PICO Always Event Synergistic effects Evidence- based practice Metabolism Therapeutic index Duration of action Patient- Centered care HIPAA Antagonist drug Normal BUN Quality improvement Therapeutic classification Free! Bioavailability Agonist drug Adverse effect Pharmacokinetics Pharmacologic classification Sensoristasis National Patient Safety Goal The Joint Commission Potency Normal GFR Half- life Onset of action Therapeutic effect Additive effects Side effect Peak and Trough levels Peak action Never Event Pharmacodynamics Normal ALT Antagonistic effects Caring Quality assurance Incompatible Systematic review Efficacy RACE Loading dose First- Pass effect Informatics Sensory Perception PICO Always Event Synergistic effects Evidence- based practice Metabolism Therapeutic index Duration of action Patient- Centered care HIPAA
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Antagonist drug
Normal BUN
Quality improvement
Therapeutic classification
Free!
Bioavailability
Agonist drug
Adverse effect
Pharmacokinetics
Pharmacologic classification
Sensoristasis
National Patient Safety Goal
The Joint Commission
Potency
Normal GFR
Half-life
Onset of action
Therapeutic effect
Additive effects
Side effect
Peak and Trough levels
Peak action
Never Event
Pharmacodynamics
Normal ALT
Antagonistic effects
Caring
Quality assurance
Incompatible
Systematic review
Efficacy
RACE
Loading dose
First-Pass effect
Informatics
Sensory Perception
PICO
Always Event
Synergistic effects
Evidence-based practice
Metabolism
Therapeutic index
Duration of action
Patient-Centered care
HIPAA